BRIEF-U.S. FDA Approves Kynmobi For Treatment Of “Off” Episodes In Patients With Parkinson’s Disease To Sunovion

BRIEF-U.S. FDA Approves Kynmobi For Treatment Of “Off” Episodes In Patients With Parkinson’s Disease To Sunovion
U.S. FDA APPROVES KYNMOBI FOR ACUTE, INTERMITTENT TREATMENT OF “OFF” EPISODES IN PATIENTS WITH PARKINSON’S DISEASE TO SUNOVION PHARMACEUTICALS Source text: (bit.ly/2LNrbwl) Further company coverage: ... read more
Source: Bing NewsPublished on 2020-05-21